Form 8-K - Current report:
SEC Accession No. 0001477932-25-001537
Filing Date
2025-03-07
Accepted
2025-03-07 16:05:10
Documents
17
Period of Report
2025-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K celz_8k.htm   iXBRL 8-K 30286
2 FORM OF INDUCEMENT WARRANT celz_ex41.htm EX-4.1 126905
3 FORM OF INDUCEMENT LETTER celz_ex101.htm EX-10.1 51487
  Complete submission text file 0001477932-25-001537.txt   376500

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA celz-20250306.xsd EX-101.SCH 5874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20250306_lab.xml EX-101.LAB 14114
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20250306_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20250306_pre.xml EX-101.PRE 8907
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20250306_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT celz_8k_htm.xml XML 3789
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41120 | Film No.: 25719978
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)